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Abstract: Dental pulp stem cells (DPSCs) represent a population of stem cells which could be useful in
oral and maxillofacial reconstruction. They are part of the periendothelial niche, where their crosstalk
with endothelial cells is crucial in the cellular response to biomaterials used for dental restorations.
DPSCs and the endothelial cell line EA.hy926 were co-cultured in the presence of Chitlac-coated
thermosets in culture conditions inducing, in turn, osteogenic or angiogenic differentiation. Cell
proliferation was evaluated by 3-[4,5-dimethyl-thiazol-2-yl-]-2,5-diphenyl tetrazolium bromide (MTT)
assay. DPSC differentiation was assessed by measuring Alkaline Phosphtase (ALP) activity and
Alizarin Red S staining, while the formation of new vessels was monitored by optical microscopy.
The IL-6 and PGE2 production was evaluated as well. When cultured together, the proliferation is
increased, as is the DPSC osteogenic differentiation and EA.hy926 vessel formation. The presence of
thermosets appears either not to disturb the system balance or even to improve the osteogenic and
angiogenic differentiation. Chitlac-coated thermosets confirm their biocompatibility in the present
co-culture model, being capable of improving the differentiation of both cell types. Furthermore,
the assessed co-culture appears to be a useful tool to investigate cell response toward newly
synthesized or commercially available biomaterials, as well as to evaluate their engraftment potential
in restorative dentistry.
Keywords: angiogenesis; chitlac thermosets; dental pulp stem cells; endothelial cells; osteogenesis
1. Introduction
Dental composite resins are types of synthetic resins used in dentistry as restorative materials or
adhesives. Among other, thermosets composed of Bisphenol A glycidylmethacrylate (BisGMA) and
triethyleneglycol dimethacrylate (TEGDMA) are receiving increasing attention as biomaterials for both
dental and orthopedic applications.
Recently, extensive research has been performed to improve implant integration, which is
influenced by the ability of biomaterials to establish proper interactions between their surface and
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the eukaryotic cells of the surrounding tissue [1]. There is growing attention to the development of
novel chemical processes enabling the introduction of bioactive molecules on the surface of these
methacrylate-based thermosets.
Travan et al. [2] developed a strategy for coating newly synthesized BisGMA/TEGDMA thermosets
with a biocompatible nanocomposite formed by a lactose modified polysaccharide (1-deoxylactate-1-y
chitosan), namely Chitlac, derived from crustacean shell. The coating converts the BisGMA/TEGDMA
surface into a “bioactive” biomaterial, able to induce specific biological responses by engaging
interactions with the surrounding living tissue at the molecular level [3].
The approach of combining aspects like proper mechanical performances and surface cell-directed
biochemical signaling aims to upgrade the BisGMA-based thermosets, already used in both dentistry [4]
and orthopaedics [5]. This could lead to new materials that can meet the complex requirements of
biomechanical and biological properties, such as the osteointegration properties expected for a “third
generation” biomaterial.
The biocompatibility of these Chitlac-coated BisGMA/TEGDMA thermosets was already assessed
in different cell types [6] as well as in minipig in-vivo model [7]. Although there is solid evidence for
the lack of cytotoxicity of this biomaterial toward eukaryotic cells [6,8,9], more focused studies need to
be conducted on their promising effects on cell differentiation.
Dental Pulp Stem Cells (DPSCs) are neural crest-derived cells with an outstanding capacity to
differentiate along multiple lineages of interest for cell therapy. In particular, they represent a specific
population of stem cells for orthopaedic and dentistry applications because of their easy extraction
from harvested dental pulp after routine surgical practice (i.e., extraction of third molars in young
adults), the achievement of osteogenic differentiation using simple in-vitro protocols and an appreciable
interaction with biomaterials [10].
DPSCs proliferate and are able to differentiate into mature odontoblasts/osteoblasts that produce a
mineralized matrix; consequently, they are often used as in-vitro models to obtain osteoblast-like cells
in a high out-turn [11]. Although a considerable amount of research has been done on the osteogenic
differentiation of DPSCs, relatively less attention has been paid to the enhancement of blood supply to
support the regeneration process.
DPSCs exist in the vessel microenvironment in-vivo and have a close association with
endothelial cells, which were proved to regulate the development of dentine/pulp tissue [12].
Dissanayaka et al. [13] directly co-cultured HUVEC and DPSCs, reporting that endothelial cells may
improve the osteo-odontogenic differentiation of DPSCs. In addition, dental pulp stem cells are able to
stabilize the vascular-like tissue structure made by HUVEC, supporting the existence of heterotypic
cell-cell crosstalk between endothelial cells and mesenchymal stem cells (MSCs), which regulates
MSCs in their local micro-environment [14]. In our experimental model, we co-cultured DPSCs with
the hybrid EA.hy926 cell line. EA.hy926 cells were generated through the fusion of HUVEC with the
human lung carcinoma cell line A549 [15] and is one of the most frequently used and best characterized
permanent human vascular endothelial cell lines [16]. Indeed EA.hy926 cells display characteristic
features of primary endothelial cells, such as the expression of the von Willebrand factor (Factor
VIII-related antigen) and synthesis of Weibel-Palade bodies, the exhibition of angiogenesis, and the
involvement in coagulation, fibrinolysis and inflammation [17].
Given the mutual benefit of the two cell types and the importance of angiogenesis during bone
regeneration, the aim of the present study was to test the effects of Chitlac-coated thermosets on the
osteo- and angiogenic potential of a DPSC/endothelial (namely EA.hy926) cell co-culture system.
2. Materials and Methods
2.1. Cell Culture
Dental Pulp Stem Cells (DPSCs) were purchased by Lonza (Lonza Group Ltd., Basel, Switzerland)
and cultured in α-MEM (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% FCS, 1%
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penicillin/streptomycin and 2 mM L-glutamine (all from Euroclone S.p.A., Milan, Italy), at 37 ◦C with
5% CO2 [11].
The endothelial cell line EA.hy926 was purchased by ATCC (LGC Standards S.r.l., Milan, Italy) and
cultured in DMEM supplemented with 10% FCS, 1% penicillin/streptomycin and 4 mM L-glutamine
(all from Euroclone S.p.A.), at 37 ◦C with 5% CO2 [18]. When indicated, the two cell types were
co-cultivated with DPCS:EA.hy926 at ratios of 1:1 and 1:5 in a mixture 1:1 of already supplemented
α-MEM and DMEM.
2.2. Thermoset Preparation and Deposition of the Polysaccharide Coating
The preparation of the thermoset samples (TS) and their coating with the polysaccharide have been
previously reported [3]. BisGMA (70% w/w) and TEGDMA (30% w/w) were mixed under vigorous
stirring at 37 ◦C. CQ (0.7% w/w) and DMAEMA (0.7% w/w) were added, and the solution was protected
from light and degassed for 12 h in a vacuum oven at 40 ◦C. The solution was poured in a Teflon
mold (ø = 14 mm, h = 2.5 mm) and the wells were covered with a PET film. The polymerization was
light-initiated with a hand cure light device (Optilux 501, λ: 400−505 nm, light power: 850 mW/cm2)
for 20 s. The post-curing was performed with a Photopol IR/UV Plus oven (Dentalfarm, Torino, Italy)
equipped with eight lamps and two spots operating in the wavelength range 320−550 nm following
the procedure: 20 min in a light oven (eight lamps), 20 min in a light oven (eight lamps) on a rotating
plate, 60 min in a light oven (eight lamps) under vacuum, and 7 min in a light oven (eight lamps plus
two spots). The thermosets were then sandpaper-polished (granulometry: 1200). In the case of the
fiber-containing composites, thermoset bars (BarTS; 20 mm length × 2 mm width × 2 mm thickness)
were reinforced by adding 50% (w/w) of longitudinally oriented E-glass fibers to the mold. Chitlac
(lactose-modified chitosan, CAS registry number 85941-43-1) was prepared according to an elsewhere
reported procedure [19], starting from a highly deacetylated chitosan (residual acetylation degree
approximately 11%). The (viscosity average) relative molar mass of chitosan was estimated to be
approximately 7 × 105. The composition of Chitlac was determined by means of 1H NMR and resulted
to be glucosamine residue = 24%; N-acetylglucosamine = 11%; and 2-(lactit-1-yl)-glucosamine = 65%.
The relative molar mass of Chitlac was estimated to be approximately 1.5 × 106.
Thermoset functionalization by Chitlac was performed by dip-coating according to an activation
procedure previously reported by the authors [2]. Negative charges were introduced on the thermoset
surface by the acidic hydrolysis of the methacrylic groups with hydrochloric acid. The activated
thermosets were immersed in 1 mL of Chitlac dissolved in water (4 mg/mL). Then, the samples were
gently stirred for 24 h, rinsed extensively with water and air-dried for 18 h.
2.3. Osteogenic Differentiation Induction
Osteogenic differentiation was induced by adding 10 nM dexamethasone, 10 mM
β-glycerophosphate and 0.2 mM ascorbic acid phosphate (all from Sigma-Aldrich) to the growth
medium. The cells were cultured in differentiating conditions up to 28 days. When indicated, the cells
were seeded and left to adhere overnight, and thermosets were added onto the cell layer surface.
2.4. Cell Viability Assay
The ell viability was evaluated after 3, 7, 14, 21 and 28 days of culture by MTT (3-[4,5-dimethyl-
thiazol-2-yl-]-2,5-diphenyl tetrazolium bromide) growth assay (Sigma-Aldrich), based on the capability
of viable cells to reduce MTT into a colored formazan product. The cells were seeded into 24-well plates
at 2 × 104 cells/well. At established time points, the medium was replaced with a fresh one containing
0.5 mg/mL MTT, and the cells were incubated for 4 h at 37 ◦C. After a further incubation of the samples
in DMSO for 30 min at 37 ◦C, 200 µL of each medium were transferred into a 96-well plate, and the
absorbance at 570 nm was measured using a Multiscan GO microplate spectrophotometer (Thermo
Fisher Scientific, Waltham, MA, USA). The values obtained in the absence of cells were considered
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as background and subtracted from the optical density values of the samples. Three independent
experiments were performed under the same experimental conditions.
2.5. Alkaline Phosphatase (ALP) Activity
The cells were seeded at 2 × 104 cells/well on 24-well plates. After 3, 7, 14, 21 and 28 days of culture,
the medium was harvested, and the ALP activity was analyzed in cell supernatants using the Alkaline
Phosphatase Assay Kit (Colorimetric) (Abcam, Cambridge, UK). The kit uses p-nitrophenyl phosphate
(pNPP) as a phosphatase substrate that turns yellow (λ max = 405 nm) when dephosphorylated by
ALP. After the supernatant collection, 80 µL/well of sample was loaded in a Falcon 96-Well Clear Flat
Bottom TC-Treated Culture Microplate in duplicate. Next, 50 µL of pNPP 5 mM/well were added and
the plate was incubated for 1 h at room temperature in the dark. After that, 20 µL of stop solution were
pipetted into each well, and the absorbance output was measured at 405 nm by means of a microplate
reader (Multiskan GO, Thermo Scientific). Each test was performed in triplicate. The calculation of the
ALP activity (U/L/min) was carried out following the manufacturer’s specifications, and each obtained
value was normalized on its protein content (µg of proteins/sample) measured by the BCA assay.
2.6. Alizarin Red S Staining
After a culture period of 28 days, the supernatants were discarded, and the cells were washed twice
in PBS with calcium and magnesium and fixed by incubating them in 4% paraformaldehyde at room
temperature for 15 min. After rinsing twice with deionized water, Alizarin Red S aqueous solution
(Sigma-Aldrich) was added at a final concentration of 40 mM and incubated at room temperature for
20 min in the dark. The excess dye was removed by washing 4 times with deionized water. Then,
1 mL of water was added to each well to prevent the cells from drying, and images were acquired. To
quantify the amount of calcium deposition using Alizarin Red Staining, 10% acetic acid was added to
each well and incubated for 30 min. The cells and acetic acid were then vortexed for 30 s and heated
up to 85 ◦C for 10 min. After cooling, the slurry was centrifuged at 20,000 g for 15 min, and 500 µL of
the supernatant were transferred to a new tube; the acid was neutralized with 200 µL of ammonium
hydroxide. Each sample was transferred in triplicate to a 96-well plate, and the optical density was
measured at 405 nm using a Multiscan GO microplate spectrophotometer (Thermo Fisher Scientific).
2.7. IL-6 and PGE2 Assay
At each time point, the cell supernatants were harvested, and the secretion of interleukin-6 (IL-6)
and prostaglandin E2 (PGE2) in the culture media was evaluated by ELISA kits (both from Enzo Life
Sciences, Farmingdale, NY, USA), according to the manufacturer’s instructions. The optical density
values were obtained by measuring the absorbance at 450 and 405 nm (for IL-6 and PGE2, respectively)
using a Multiscan GO microplate spectrophotometer (Thermo Fisher Scientific).
2.8. Tubular Network Formation on Matrigel
The Matrigel Matrix (10 mg/mL) (Corning Inc. Life Sciences, MA, USA) was thawed and 0.289 mL
was added to each well of a 24-well plate. After an incubation of 60 min at 37 ◦C, the EA.hy926 cells
(105/300 µL/well) were plated in each well. Thermosets were added where indicated. Twenty-four
hours after the EA.hy926 plating, DPSCs were added to the culture at the ratio of 1:1 where indicated.
Images were taken following an additional 24 or 48 h of incubation, by means of a Leica DM 4000 light
microscope (Leica Cambridge Ltd., Cambridge, UK) at a magnification of 4× and 10×. The LAS X
software (Leica) was used to quantify the length and diameter of the vessels.
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2.9. Statistics
A statistical analysis was performed using Prism 5 (GraphPad software, San Diego, CA, USA)
and the pair-wise comparison t-student test. The results were expressed as the means ± SD. Values of
p < 0.05 were considered statistically significant.
3. Results
3.1. Biocompatibility of Chitlac Thermosets
DPSCs were grown in the presence of Chitlac thermosets, and of two different concentrations of
endothelial cells (1:1 and 1:5) for 28 days, and their metabolic activity was evaluated at different time
intervals (Figure 1). The MTT analysis highlights that thermosets exert only a slight cytotoxicity on
DPSCs after 3 days with respect to DPSCs alone (O.D. 0.54 and 1.17, respectively) which seems to be
counteracted after 7 and 14 days of culture, being the O.D. values similar to the ones of cells alone.
After 28 days of culture, the metabolic activity of DPSCs appears indeed to be the same either with or
without thermoset (O.D. 3.04 and 3.21, respectively). In parallel, the addition of the EA.hy926 cells to
the culture system with a thermoset, either in the 1:1 or in the 1:5 proportion, significantly increases the
cellular metabolic activity in almost all the experimental conditions, but mainly after 21 days of culture
(O.D. DPSCs Th = 1.27; O.D. DPSC:EA.hy926 1:1 = 3.58; O.D. DPSC:EA.hy926 1:5 = 3.44).
Figure 1. MTT assay in control and Chitlac coated BisGMA/TEGDMA methacrylic thermosets
treated DPSC/EA.hy926 coculture for 3, 7, 14, 21, and 28 days. The data shown are the mean (±SD)
(n = 3).* DPSC:EA.hy926 1:1 and 1:5 vs. DPSC of the same day of culture, p < 0.05; $ DPSC Th vs. DPSC
of the same day of culture, p < 0.05; ¥ DPSC:EA.hy926 1:1 Th vs. DPSC:EA.hy926 1:1 of the same day of
culture, p < 0.05; # DPSC:EA.hy926 1:1 Th and DPSC:EA.hy926 1:5 Th vs. DPSC Th control of the same
day of culture, p < 0.05; # DPSC:EA.hy926 1:5 Th vs. DPSC:EA.hy926 1:5 of the same day of culture,
p < 0.05.
3.2. Enzymatic Activity of Alkaline Phosphatase in the Presence of Chitlac Thermosets
Despite the slight cytotoxicity exerted by Chitlac-coated BisGMA/TEGDMA methacrylic
thermosets, their presence in the experimental conditions does not affect the activity of the DPSC
alkaline phosphatase (ALP), whose results gradually enhanced in a time-dependent manner in the
presence of the thermoset with respect to the control sample, mainly after 21 and 28 days of culture
(Figure 2A). In general, the presence of endothelial cells, both in 1:1 and 1:5 proportion, increases the
ALP activity. However, while during the first 7 days of culture no difference is disclosed in the two
concentrations of EA.hy926 cells, in the later experimental points the ALP activity shows a tendency to
be higher when the endothelial cells are five times more numerous than the stem cells.
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3.3. Alizarin Red S Staining of Cell Cultures Grown in the Presence of Chitlac Thermosets
The Alizarin Red S Staining (ARS) performed after 28 days of culture shows an intense staining
mainly of the DPSCs co-cultivated with the EA.hy926, both in 1:1 and 1:5 conditions, either alone or in
the presence of thermosets (Figure 2B). The quantification of ARS confirms a greater mineralized matrix
deposition when endothelial cells are present with respect to DPSCs alone (0.449 µM and 0.441 µM
versus 0.068 µM). The calcium deposition is enhanced by the presence of the thermoset as well, as the
highest value of ARS concentration registered in the experimental set is where DPSCs are co-cultured
with endothelial cells at 1:1, in the presence of the thermoset (1.10 µM) (Figure 2C).
Figure 2. (A) Quantitative determination of the ALP levels in the induced cultures at different time
points. All results are represented as the mean values ± SD (n = 3). * DPSC:EA.hy926 1:1 and 1:5
vs. DPSC of the same day of culture, p < 0.05; $ DPSC:EA.hy926 1:5 Th vs. DPSC:EA.hy926 1:5
of the same day of culture, p < 0.05; ¥ DPSC:EA.hy926 1:5 Th day 28 vs. DPSC:EA.hy926 1:5 day
28, p < 0.05; # DPSC Th day 28 vs. DPSC day 28, p < 0.05; ** DPSC:EA.hy926 1:5 vs. 1:1 relative
control of the same day of culture, p < 0.05; # DPSC:EA.hy926 1:1 Th and DPSC:EA.hy926 1:5 Th vs.
DPSC Th of the same day of culture, p < 0.05. ## DPSC:EA.hy926 1:5 Th vs. DPSC:EA.hy926 1:1 Th,
p < 0.05. (B) Alizarin Red detection of mineralization in induced cultures for 28 days. Alizarin Red
stained cultures (Upper line from the left: DPSC, DPSC:EA.hy926 1:1 and DPSC:EA.hy926 1:5. Lower
line from the left: DPSC Th, DPSC:EA.hy926 1:1 Th and DPSC:EA.hy926 1:5 Th). (C) Quantitative
determination of Alizarin Red-stained mineralized nodules in cultures. * DPSC:EA.hy926 1:1 and 1:5
vs. DPSC, p < 0.05; $ DPSC:EA.hy926 1:1 Th and 1:5 Th vs. DPSC Th, p < 0.05; ¥ DPSC:EA.hy926
1:1 Th vs. DPSC:EA.hy926 1:1, p < 0.05; # DPSC:EA.hy926 1:5 Th vs. DPSC:EA.hy926 1:5, p < 0.05;
** DPSC:EA.hy926 1:5 Th vs. DPSC:EA.hy926 1:1 Th, p < 0.05.
3.4. Cytokines Release
The interleukin-6 and the prostaglandin E2 production, normalized on the MTT values, is shown
in Figure 3. Notably, the addition of EA.hy926 to the culture gradually increases the IL-6 production,
when compared to the relative DPSC control. Likewise, when the thermoset is placed onto the
co-culture monolayer, the cytokine secretion is dramatically increased with respect to the samples
without thermosets, with an almost 5-fold increase in the DPSC:EA.hy926 1:5 Th with respect to
DPSC:EA.hy926 1:5 (Figure 3).
In alignment with this, PGE2 is significantly released, mainly in the 1:1 co-culture system when
thermosets are present. In the 1:5 coculture system, the PGE2 release is lower than in the 1:1 condition,
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but it is higher than in the control sample. As for the samples without thermosets, an increase in the
PGE2 production is detectable only in the 1:1 co-culture (Figure 3).
Figure 3. ELISA assay for the IL-6 (upper graph) and PGE2 (lower graph) secretions of cultures at
different time points. The secretion levels are reported as pg/mL/OD MTT values. The data shown are
the mean (±SD) (n = 3).* DPSC:EA.hy926 1:1 and 1:5 vs. DPSC, p < 0.05; $ DPSC:EA.hy926 1:1 Th and 1:5
Th vs. DPSC Th, p < 0.05; ¥ DPSC:EA.hy926 1:1 Th vs. DPSC:EA.hy926 1:1, p < 0.05; # DPSC:EA.hy926
1:5 Th vs. DPSC:EA.hy926 1:5, p < 0.05; ** DPSC:EA.hy926 1:5 Th vs. DPSC:EA.hy926 1:1 Th, p < 0.05.
3.5. Tubular Network Formation on Matrigel
When the endothelial cells are seeded alone (Figure 4A), they form a well-established network
within 24 h, which after additional 24 h (Figure 4B) shows a tendency to dissolve with longer but
thinner tubules (see the two graphs). When the DPSCs are added to the EA.hy926 cells after 24 h
(Figure 4C), they stabilize the tubular network. The length and diameter of the tubules appear similar
in endothelial cells alone after 24 h (EA.hy926 24 h) and in the co-culture sample after an additional 24 h
(DPSC/EA.hy926 48 h). In addition, while the tubules formed by EA.hy926 alone almost disappeared
after 72 h (data not shown), the presence of the mesenchymal cells maintains the network organization
(Figure 4D) with a thickening of the vessels. The addition of Chitlac-coated BisGMA/TEGDMA
methacrylic thermosets (Figure 4E–H) always results in tubules with an increased diameter, while the
effects on the vessel length are less clear (see the two graphs). The thermosets seem to promote the
formation of longer tubules at early experimental times, both in the endothelial cells alone (EA.hy926
24 h) and in the co-culture (DPSC/EA.hy926 48 h), while a shorter vessel or no effects are present
at late experimental times (EA.hy926 48 h and DPSC/EA.hy926 72 h). Generally, in the presence of
the biomaterial, the tubules are longer and thicker, with a tendency to shorten with time (see the
two graphs).
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Figure 4. Vessel formation and stabilization by DPSC. (A,B,E,F) Phase-contrast light microscopy
analysis of the vessel formation on the Matrigel of EA.hy926 alone. (C,D,G,H) Phase-contrast light
microscopy analysis of the vessel formation on the Matrigel of the DPSC/EA.hy926 co-culture. The two
graphs represent the tubular length (left) and the tubular diameter (right) in microns (µm). The data
are the mean (±SD) (n = 6). * EA.hy926 48 h no th vs. EA.hy926 24 h no th, p < 0.05; $ DPSC/EA.hy926
72 h no th vs. DPSC/EA.hy926 48 h no th, p < 0.05; ¥ Th vs. no th relative control, p < 0.05; # EA.hy926
48 h th vs. EA.hy926 24 h th, p < 0.05; ** DPSC/EA.hy926 72 h Th vs. DPSC/EA.hy926 48 h Th, p < 0.05.
4. Discussion
Composite materials are increasingly used in dental, as well as in orthopaedic restoration.
While mechanical bulk properties are guaranteed by the presence of reinforcing fibers, in-vitro and
in-vivo performances of these materials are ultimately driven by their ability to establish proper
interactions between their surface and the surrounding tissues. Bisphenol A glycidylmethacrylate
(BisGMA)/triethyleneglycol dimethacrylate (TEGDMA) thermosets coated with a lactose-modified
chitosan are an example of biomaterials for dental applications that are receiving growing interest for
orthopedic applications [3].
Bone regeneration necessitates the interaction of cells, of growth factors, of the extracellular matrix
and of the blood supply [20,21]. For this reason, the induction and the maintenance of the angiogenesis
are very important during the process of bone regeneration. Osteoblasts contribute to bone regeneration
by developing the bone structure and by producing extracellular matrix proteins as well as regulators
of matrix mineralization [22]. Endothelial cells are equally important in bone regeneration, given
that they are a source of modulators of bone development and of secreting molecules which control
cell proliferation [23]. Based on this evidence, the in-vitro osteogenic and angiogenic potential of a
coculture of DPSCs and EA.hy926 cells, grown in the presence of Chitlac-coated BisGMA/TEGDMA
thermosets, was evaluated.
First, the evaluation of the metabolic activity in different experimental conditions confirms the
mutual beneficial effects exerted by the two cell types on each other. These findings are in line with
already published papers which highlighted communal signaling pathways between angiogenesis and
osteogenesis [24] and confirmed a lively cross-talk between bone and endothelial progenitors [25,26].
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The presence of EA.hy926 endothelial cells increases the alkaline phosphatase activity, an important
differentiation marker which indicates the commitment of stem cells to become osteoblasts, in DPSCs
induced to osteogenic differentiation, as already observed in different experimental systems [27,28].
In alignment with current literature [29], the Alizarin Red S staining confirms the presence of calcium
deposition and a mineralized matrix, which is predictive of the establishment of the advanced osteogenic
differentiation, mainly evidenced in the presence of both endothelial cells and Chitlac-thermosets.
As for the cross-talk between the dental pulp and endothelial cells, many molecules are involved
in their mutual beneficial effect. Endothelin-1, a paracrine factor mainly secreted by endothelial
cells, regulates osteo- and chondrogenesis without affecting adipogenic differentiation, through Akt
signaling [30]. In addition, ECs are capable of secreting, among others, the bone morphogenic protein
and the fibroblast growth factor, both well known for their role in bone formation [31]. Endothelial
cells are furthermore capable of modulating other types of cell differentiation, to the point of having a
therapeutic potential in osteoarthritis [32].
On the other hand, DPSCs assist and improve the vessel formation of EA.hy926 cells, confirming
the crucial role of mesenchymal stem cells in angiogenesis, even in very different experimental
systems [33]. The paracrine factors that are involved here are certainly the proteins of the VEGF family,
released by the DPSCs for autocrine purposes. In particular, the VEGFA is known for being secreted by
mesenchymal stem cells during osteogenesis, with the aim of recruiting other stem cells [34], while the
miRNA 195 regulates osteogenesis in MSCs and the paracrine effect in angiogenesis [35]. The crosstalk
and paracrine production of these cell types are so copious that their co-injection is considered to have
a therapeutic potential in muscle recovery [36].
The main outcome of this paper, however, is the beneficial effect exerted by the Chitlac-coated
BisGMA/TEGDMA thermosets both on the osteogenic differentiation of DPSCs and on the vessel
formation by EA.hy926 cells. The ability of the Chitlac coating to limit cytotoxicity was already
demonstrated [8], but in the present paper the experimental model is more complex and challenging,
being made of two cell types and the biomaterial together. The thermosets seem to slightly affect
the cell metabolic activity but only at early experimental times and when DPSCs are cultivated
alone, confirming their biocompatibility once the system is stabilized, i.e., in the second half of the
differentiation timespan. Moreover, their effects are not limited to cell viability, but an improvement of
osteogenic differentiation was recorded. In-vivo tests in minipigs showed that polysaccharide-coated
thermoset implants display a good biocompatibility and an ability for osseointegration [3]. In the
present experimental system, these two qualities are reinforced by the effects on bone differentiation,
as demonstrated by the alkaline phosphatase activity, which has its highest value at late experimental
points and when thermosets and endothelial cells are added to the DPSCs. Alkaline phosphatase is a
well-known marker of osteogenic differentiation, whose activity could be predictive of the in vivo bone
forming capacity of human bone marrow stromal cells [37]. The Alizarin Red S staining, consistent with
already published data [13], confirms the ability of the biomaterial to induce osteogenic differentiation
and matrix mineralization.
In the attempt to investigate the inflammatory pathway, IL-6 and PGE2 secretion were measured.
Given that interleukin-6 is mainly produced in the presence of the thermoset, when no cytotoxicity is
present and the other parameters discussed above indicate a well-established osteogenic differentiation,
its release seems to be more consistent with bone generation than with inflammation. Since the IL-6
can be involved in many pathways [38] and its role in differentiation was already demonstrated [6], we
can suggest a role for this interleukin in the bone formation happening in our experimental model.
On the other hand, the ability of chitosan, whose modified form, Chitlac, coats the thermosets, to
promote osteogenesis is so largely proven, that it has been recently studied in combination with other
biomaterials in bone regeneration [39,40].
As for PGE2, this prostanoid can be involved in many differentiation processes, including
osteogenic differentiation [11], but it is mainly associated with angiogenesis. Since the PGE2 production
is not striking and the highest values are found in the same experimental conditions that enhance
Nanomaterials 2019, 9, 928 10 of 12
angiogenesis (i.e., in the presence of DPSCs and thermosets), we can suggest that PGE2 is related to
vessel formation. These findings can be confirmed by a well-known role for chitosan in promoting
wound healing, angiogenesis and other regenerative processes [41].
5. Conclusions
Although further studies are needed to clarify the crammed cross-talk in a complex system like the
one that was the object of the present study, it is clear that the endothelial cells and the dental pulp cells
have mutual beneficial effects. Chitlac-coated thermosets, as novel and promising biomaterials, seem
to integrate well into the culture system, being not only biocompatible but also actually improving
the differentiation potential of both cell types. Their ability to stimulate both osteo- and angiogenic
differentiation could be essential in their possible use as implants, both in dentistry and orthopaedics.
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